Terms: = Bone cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
6 results:
1. csf3r-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
[TBL] [Abstract] [Full Text] [Related]
2. G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.
Karagiannidis I; Salataj E; Said Abu Egal E; Beswick EJ
Cytokine; 2021 Jun; 142():155479. PubMed ID: 33677228
[TBL] [Abstract] [Full Text] [Related]
3. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract] [Full Text] [Related]
4. csf3r Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract] [Full Text] [Related]
5. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with csf3r mutation: a case report and literature review.
Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
[TBL] [Abstract] [Full Text] [Related]
6. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
Elliott MA; Tefferi A
Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199
[TBL] [Abstract] [Full Text] [Related]
